$SRM Entertainment, Inc.(SRM)$ Witnessed $SRM Entertainment, Inc.(SRM)$ rocket from $1.5 on June 16 to $7.7 today amid reverse merger news with Tron backed by crypto mogul Justin Sun (net worth $8.5B). Remember when $SharpLink Gaming(SBET)$ mooned 50x after Ethereum adoption rumors? With Sun's deep pockets (including $100M+ in Trump-linked crypto ventures), this could be crypto's next parabolic play. Caveat emptor though - either strike gold or get struck.
$CoreWeave, Inc.(CRWV)$ Now it makes sense why HSBC set $HSBC Holdings PLC(HSBC)$ 's target at $32. When the stock rockets to $320 by Jan 2026, they'll execute a 10-for-1 split - voilà, right back to the magic number.
$CoreWeave, Inc.(CRWV)$ The next moment you blink, it might double. People love to kick those who are down, but when the tide turns, excitement follows.
$CoreWeave, Inc.(CRWV)$ Didn't Michael Intrator state the delay by Core Scientific was just one week, tied to rain in Denton, Texas preventing concrete spreading?
$Occidental(OXY)$ Closing in on the wedge's apex daily, with 50MA forming robust support. RSI hints at squeeze potential. But Middle East tensions hold $Meta Platforms, Inc.(META)$ 's puppet strings - let's see how this 4-day week plays out
$Canaan Inc.(CAN)$ This stock's brewing something massive. Q3 earnings drop Nov 14th with EPS estimated at -$0.008, but mark my words - that Texas bitcoin deal just inked will flip the script. Shorts laughing now will be scrambling when analysts upgrade. 52-week high? More like trampoline floor. Keep calm and carry long!
$CoreWeave, Inc.(CRWV)$ Missing this AI bullet train would be pure folly. Countless investors will facepalm when $Oracle(ORCL)$ makes its cloud-powered leap. The hyperscalers' war chests are overflowing, and market hunger rivals a black hole's appetite. Oracle's pivot shows how swiftly tech titans can dominate emerging sectors.
$Figma(FIG)$ The entire stock market is overpriced - yet we keep buying and profiting. My IPO golden rule: monitor the opening day's low. If price breaches that level within 7 trading days, instant buy signal triggers. Remarkably effective every time, with prices oscillating between historical lows and highs like the 84.11-142.92 sweet zone.
Is everyone sleeping on $Novo-Nordisk A/S(NVO)$ 's FDA submission for 25mg oral Semaglutide? 15-17% weight loss data with decision expected by year-end. Their EU application for 7.2mg Wegovy injection shows over 21% efficacy. Pipeline bombshells CagriSema and oral Amycretin are crushing Phase 3 trials. Despite $Novo-Nordisk A/S(NVO)$ 's marketing team needing lessons from $Eli Lilly(LLY)$ , becoming first-mover in oral obesity meds could launch their market cap into orbit. Medicare coverage would be the ultimate catalyst.